| Year |
Citation |
Score |
| 2023 |
Paxson AI, Chang LH, Gard JMC, Harryman WL, Nelson CS, Salmon SB, Marr KD, Wachsmuth LM, Ramanathan A, Ran J, Kapoor A, Marugan JJ, Henderson MJ, Sanchez TW, Cress AE. Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells. Frontiers in Cell and Developmental Biology. 11: 1285372. PMID 38046670 DOI: 10.3389/fcell.2023.1285372 |
0.39 |
|
| 2023 |
Marr KD, Gard JMC, Harryman WL, Keeswood EJ, Paxson AI, Wolgemuth C, Knudsen BS, Nagle RB, Hazlehurst L, Sorbellini M, Cress AE. Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo. Biophysical Journal. PMID 37766428 DOI: 10.1016/j.bpj.2023.09.016 |
0.359 |
|
| 2023 |
Jensen CC, Clements AN, Liou H, Ball LE, Bethard JR, Langlais PR, Toth RK, Chauhan SS, Casillas AL, Daulat SR, Kraft AS, Cress AE, Miranti CK, Mouneimne G, Rogers GC, et al. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology. 222. PMID 37042842 DOI: 10.1083/jcb.202208136 |
0.364 |
|
| 2023 |
Marr KD, Ignatenko NA, Warfel NA, Batai K, Cress AE, Pollock GR, Wong AC, Lee BR. Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins. Frontiers in Oncology. 12: 1083150. PMID 36727054 DOI: 10.3389/fonc.2022.1083150 |
0.304 |
|
| 2022 |
Ryniawec JM, Coope MR, Loertscher E, Bageerathan V, de Oliveira Pessoa D, Warfel NA, Cress AE, Padi M, Rogers GC. GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors. Diagnostics (Basel, Switzerland). 12. PMID 35328229 DOI: 10.3390/diagnostics12030676 |
0.385 |
|
| 2022 |
Harryman WL, Marr KD, Nagle RB, Cress AE. Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers. Frontiers in Cell and Developmental Biology. 10: 837585. PMID 35300411 DOI: 10.3389/fcell.2022.837585 |
0.341 |
|
| 2021 |
Sun BL, Tang L, Sun X, Garcia AN, Camp SM, Posadas E, Cress AE, Garcia JGN. A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression. Pharmaceuticals (Basel, Switzerland). 14. PMID 34959723 DOI: 10.3390/ph14121322 |
0.371 |
|
| 2021 |
Pollan SG, Teng PC, Jan YJ, Livingstone J, Huang C, Kim M, Mariscal J, Rodriguez M, Chen JF, You S, DiVizio D, Boutros PC, Chan KS, Rasorenova O, Cress A, et al. Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. American Journal of Clinical and Experimental Urology. 9: 350-366. PMID 34541033 |
0.414 |
|
| 2020 |
Kelly GT, Faraj R, Dai Z, Cress AE, Wang T. A mutation found in esophageal cancer alters integrin β4 mRNA splicing. Biochemical and Biophysical Research Communications. 529: 726-732. PMID 32736699 DOI: 10.1016/J.Bbrc.2020.06.078 |
0.399 |
|
| 2020 |
Nollet EA, Cardo-Vila M, Ganguly SS, Tran JD, Schulz VV, Cress A, Corey E, Miranti CK. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. PMID 32565538 DOI: 10.1038/S41388-020-1370-9 |
0.406 |
|
| 2020 |
Marr* K, Ignatenko N, Warfel N, Batai K, Cress A, Pollock G, Wong A, Lee B. MP09-07 USE OF 3D VIDEO MICROSCOPY OF HUMAN-DERIVED PROSTATE ORGANOIDS TO ASSESS FEATURES OF EARLY INVASIVE PROSTATE CANCER The Journal of Urology. 203: e118. DOI: 10.1097/Ju.0000000000000829.07 |
0.432 |
|
| 2019 |
Wang M, Rogers GC, Cress AE. Immunofluorescence-based Determination of Centrosome Number in Tissue Samples. Bio-Protocol. 9: e3396. PMID 33654897 DOI: 10.21769/BioProtoc.3396 |
0.309 |
|
| 2019 |
Harryman WL, Warfel NA, Nagle RB, Cress AE. The Tumor Microenvironments of Lethal Prostate Cancer. Advances in Experimental Medicine and Biology. 1210: 149-170. PMID 31900909 DOI: 10.1007/978-3-030-32656-2_8 |
0.458 |
|
| 2019 |
Wang M, Nagle RB, Knudsen BS, Cress AE, Rogers GC. Centrosome loss results in an unstable genome and malignant prostate tumors. Oncogene. PMID 31477840 DOI: 10.1038/S41388-019-0995-Z |
0.482 |
|
| 2019 |
Rubenstein CS, Gard JMC, Wang M, McGrath JE, Ingabire N, Hinton JP, Marr KD, Simpson SJ, Nagle RB, Miranti CK, Warfel NA, Garcia JGN, Arif-Tiwari H, Cress AE. Gene editing of α6 integrin inhibits muscle invasive networks and increases cell-cell biophysical properties in prostate cancer. Cancer Research. PMID 31337652 DOI: 10.1158/0008-5472.Can-19-0868 |
0.464 |
|
| 2019 |
Wang M, Hinton JP, Gard JMC, Garcia JGN, Knudsen BS, Nagle RB, Cress AE. Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell-cell and cell-ECM interactions. Molecular Biology of the Cell. mbcE18100652. PMID 30865564 DOI: 10.1091/Mbc.E18-10-0652 |
0.433 |
|
| 2019 |
Wang M, Knudsen BS, Nagle RB, Rogers GC, Cress AE. A method to quantify centrosomes at single-cell level in human normal and cancer tissue. Molecular Biology of the Cell. mbcE18100651. PMID 30699045 DOI: 10.1091/Mbc.E18-10-0651 |
0.42 |
|
| 2018 |
Saylor J, Ma Z, Goodridge HS, Huang F, Cress AE, Pandol SJ, Shiao SL, Vidal AC, Wu L, Nickols NG, Gertych A, Knudsen BS. Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining. Frontiers in Immunology. 9: 2925. PMID 30619287 DOI: 10.3389/Fimmu.2018.02925 |
0.309 |
|
| 2018 |
Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE. Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Molecular Cancer Research : McR. PMID 29759989 DOI: 10.1158/1541-7786.Mcr-17-0589 |
0.508 |
|
| 2018 |
Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, et al. Regulation of inside-out β1-integrin activation by CDCP1. Oncogene. PMID 29511352 DOI: 10.1038/S41388-018-0142-2 |
0.523 |
|
| 2018 |
Pollan S, Sperger J, Lang J, Huang F, Zheng J, Morrissey C, Cress AE, Spassov D, Moasser M, Carter W, Knudsen B. Abstract B096: CDCP1, a potential noninvasive biomarker in circulating tumor cells for treatment of prostate cancer with FAK inhibitors Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B096 |
0.493 |
|
| 2018 |
Saylor J, Weterings E, Ellis N, Hinton J, Roberts E, Cress A, Knudsen B. Abstract B095: An automated tissue staining and quantitative digital image analysis pipeline for quantification of DNA damage repair at the single-cell level Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B095 |
0.395 |
|
| 2018 |
Wang M, Knudsen BS, Rogers GC, Cress AE. Abstract A049: Centrosome loss and chromosomal instability in prostate tumor progression Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A049 |
0.463 |
|
| 2017 |
Harryman WL, Gard JMC, Pond KW, Simpson SJ, Heppner LH, Hernandez-Cortes D, Little AS, Eschbacher JM, Cress AE. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy. Neoplasia (New York, N.Y.). 19: 919-927. PMID 28954241 DOI: 10.1016/J.Neo.2017.08.005 |
0.429 |
|
| 2016 |
Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochimica Et Biophysica Acta. PMID 27678419 DOI: 10.1016/J.Bbcan.2016.09.005 |
0.481 |
|
| 2016 |
Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE. A basal cell defect promotes budding of prostatic intraepithelial neoplasia. Journal of Cell Science. PMID 27609833 DOI: 10.1242/Jcs.188177 |
0.464 |
|
| 2016 |
Das L, Anderson TA, Gard JM, Sroka IC, Strautman SR, Nagle RB, Morrissey C, Knudsen BS, Cress AE. Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells. Journal of Cellular Biochemistry. PMID 27509031 DOI: 10.1002/Jcb.25673 |
0.394 |
|
| 2016 |
Harryman WL, Pond E, Singh P, Little AS, Eschbacher JM, Nagle RB, Cress AE. Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers. American Journal of Translational Research. 8: 940-54. PMID 27158381 |
0.315 |
|
| 2016 |
Sroka IC, Chopra H, Das L, Gard JM, Nagle RB, Cress AE. Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin. Journal of Cellular Biochemistry. 117: 491-9. PMID 26239765 DOI: 10.1002/Jcb.25300 |
0.515 |
|
| 2016 |
Pond E, Harryman WL, Cress AE. Abstract 09: Laminin binding integrin copy number variations in distinct types of epithelial cancers Clinical Cancer Research. 22: 9-9. DOI: 10.1158/1557-3265.Pmsclingen15-09 |
0.405 |
|
| 2016 |
Das L, Anderson TA, Gard JM, Sroka IC, Strautman SR, Nagle RB, Morrissey C, Knudsen BS, Cress AE. Abstract A60: Loss of α3 integrin expression promotes α6 integrin internalization to Rab4 vesicles and migration of human prostate cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A60 |
0.453 |
|
| 2015 |
Fu P, Usatyuk PV, Jacobson J, Cress AE, Garcia JG, Salgia R, Natarajan V. Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function. Pulmonary Circulation. 5: 619-30. PMID 26697169 DOI: 10.1086/683693 |
0.32 |
|
| 2015 |
Qian Z, Zhou T, Gurguis CI, Xu X, Wen Q, Lv J, Fang F, Hecker L, Cress AE, Natarajan V, Jacobson JR, Zhang DD, Garcia JG, Wang T. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival. Scientific Reports. 5: 16889. PMID 26596768 DOI: 10.1038/Srep16889 |
0.312 |
|
| 2015 |
Chen W, Epshtein Y, Ni X, Dull RO, Cress AE, Garcia JG, Jacobson JR. Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress. Scientific Reports. 5: 16529. PMID 26572585 DOI: 10.1038/Srep16529 |
0.303 |
|
| 2015 |
Song S, Jacobson KN, McDermott KM, Reddy SP, Cress AE, Tang H, Dudek SM, Black SM, Garcia JG, Makino A, Yuan JX. ATP Promotes Cell Survival Via Regulation of Cytosolic [Ca2+] and Bcl-2/Bax Ratio in Lung Cancer Cells. American Journal of Physiology. Cell Physiology. ajpcell.00092.2015. PMID 26491047 DOI: 10.1152/Ajpcell.00092.2015 |
0.372 |
|
| 2015 |
Samulitis BK, Pond KW, Pond E, Cress AE, Patel H, Wisner L, Patel C, Dorr RT, Landowski TH. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biology & Therapy. 16: 43-51. PMID 25485960 DOI: 10.4161/15384047.2014.986967 |
0.343 |
|
| 2015 |
Algotar A, Cress A, Nagle R, Sokoloff M, Singh P, Behnejad R, Stratton S. Association of ERG-PTEN expression profile of prostate biopsy with PSA velocity. Journal of Clinical Oncology. 33: 92-92. DOI: 10.1200/Jco.2015.33.7_Suppl.92 |
0.4 |
|
| 2015 |
Algotar AM, Cress A, Nagle R, Sokoloff M, Behnejad R, Drinkwitz D, Lodhia N, Thompson P, Stratton SP. DNA damage and repair markers to improve accuracy of prostate cancer diagnosis and identification of aggressive disease. Journal of Clinical Oncology. 33: e16012-e16012. DOI: 10.1200/Jco.2015.33.15_Suppl.E16012 |
0.371 |
|
| 2015 |
Samulitis Bk, Pond E, Pond K, Cress AE, Dorr RT, Landowski TH. Abstract B42: Adaptive drug resistance is associated with phenotypic reprogramming and hypersensitivity to HDAC inhibitors Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B42 |
0.32 |
|
| 2014 |
Kacsinta AD, Rubenstein CS, Sroka IC, Pawar S, Gard JM, Nagle RB, Cress AE. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines. Biochemical and Biophysical Research Communications. 454: 335-40. PMID 25450398 DOI: 10.1016/J.Bbrc.2014.10.073 |
0.797 |
|
| 2014 |
Landowski TH, Gard J, Pond E, Pond GD, Nagle RB, Geffre CP, Cress AE. Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model. Molecular Cancer Therapeutics. 13: 1558-66. PMID 24739392 DOI: 10.1158/1535-7163.Mct-13-0962 |
0.399 |
|
| 2014 |
Das L, Anderson TA, Gard JMc, Sroka IC, Strautman SR, Nagle RB, Knudsen BS, Cress A. Abstract 4979: A6B1 integrin internalization is increased by loss of A3B1 expression and promotes migration of human prostate cancer cells Cancer Research. 74: 4979-4979. DOI: 10.1158/1538-7445.Am2014-4979 |
0.394 |
|
| 2014 |
Rubenstein CS, Gard J, Nagle RB, Landowski TH, Cress AE. Abstract 3152: Integrin α6β1 dependent collective cell migration in prostate cancer metastasis Cancer Research. 74: 3152-3152. DOI: 10.1158/1538-7445.Am2014-3152 |
0.548 |
|
| 2014 |
Algotar AM, Cress AE, Nagle RB, Drinkwitz D, Lodhia NS, Thompson PA, Stratton SP. Abstract 1856: DNA damage and repair markers (H2AX and RAD51) improve accuracy of prostate cancer diagnosis and improve identification of aggressive disease Cancer Research. 74: 1856-1856. DOI: 10.1158/1538-7445.Am2014-1856 |
0.394 |
|
| 2012 |
Chopra H, Riquer ZPE, Cress AE, Sroka IC. Abstract 502: Schwann cells promote tumor cell invasion through regulation of the laminin receptorA6B1 Cancer Research. 72: 502-502. DOI: 10.1158/1538-7445.Am2012-502 |
0.504 |
|
| 2012 |
Pond ED, Sroka TC, Gard JM, Pawar SC, Nagle RB, Cress AE. Abstract 4345: Inadequate repair of ionizing radiation damage: A consequence of the invasive tumor phenotype Cancer Research. 72: 4345-4345. DOI: 10.1158/1538-7445.Am2012-4345 |
0.81 |
|
| 2012 |
Anderson TA, Gard JM, Sroka IC, Strautman SR, Morrissey C, Knudsen BS, Cress AE. Abstract 2457: Laminin receptor cross-talk stimulates receptor internalization and migration of human prostate cancer cells Cancer Research. 72: 2457-2457. DOI: 10.1158/1538-7445.Am2012-2457 |
0.484 |
|
| 2011 |
Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Molecular Pain. 7: 81. PMID 22014040 DOI: 10.1186/1744-8069-7-81 |
0.325 |
|
| 2011 |
Emmons MF, Gebhard AW, Nair RR, Baz R, McLaughlin ML, Cress AE, Hazlehurst LA. Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype. Molecular Cancer Therapeutics. 10: 2257-66. PMID 21980133 DOI: 10.1158/1535-7163.Mct-11-0149 |
0.394 |
|
| 2011 |
Nagle RB, Cress AE. Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis. Prostate Cancer. 2011: 249290. PMID 21949592 DOI: 10.1155/2011/249290 |
0.424 |
|
| 2011 |
Sroka IC, Sandoval CP, Chopra H, Gard JM, Pawar SC, Cress AE. Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer. Molecular Cancer Research : McR. 9: 1319-28. PMID 21824975 DOI: 10.1158/1541-7786.Mcr-11-0080 |
0.811 |
|
| 2011 |
Gebhard AW, Emmons MF, Argilagos RF, McLaughlin M, Koomen J, Cress AE, Hazlehurst LA. Abstract 3628: The forced interaction of α4 integrin and CD44 by the novel peptide HYD1 may be a determinant of HYD1-induced cell death in multiple myeloma Cancer Research. 71: 3628-3628. DOI: 10.1158/1538-7445.Am2011-3628 |
0.371 |
|
| 2011 |
Sroka IC, Gard JM, McDaniel K, Nagle RB, Cress AE. Abstract 1543: Potential role of Schwann cells and laminin adhesion in prostate cancer perineural invasion Cancer Research. 71: 1543-1543. DOI: 10.1158/1538-7445.Am2011-1543 |
0.499 |
|
| 2011 |
Sroka IC, Gard JMC, Pond E, Pawar SC, Nagle RB, Cress AE. Abstract 1534: Laminin binding integrin functions in human bone metastatic cancer Cancer Research. 71: 1534-1534. DOI: 10.1158/1538-7445.Am2011-1534 |
0.81 |
|
| 2011 |
Emmons MF, Gebhard A, Mclaughlin M, Cress A, Hazlehurst L. Abstract 1523: α4 integrin expression is a determinant for activity of the integrin antagonist HYD1 in multiple myeloma cell lines and patient specimens Cancer Research. 71: 1523-1523. DOI: 10.1158/1538-7445.Am2011-1523 |
0.365 |
|
| 2010 |
Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, Cress AE. The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. Journal of Cellular Physiology. 224: 283-8. PMID 20432448 DOI: 10.1002/Jcp.22149 |
0.532 |
|
| 2010 |
Cress AE, Sandoval CP, Gard JMC, Pawar SC, Sroka IC, Abril ER, Nagle RB. Abstract 534: Invasive human prostate cancer and integrin cleavage: Potential role of uPAR contributed by macrophages Cancer Research. 70: 534-534. DOI: 10.1158/1538-7445.Am10-534 |
0.817 |
|
| 2010 |
Emmons M, Nair R, McLaughlin M, Eschrich S, Cress A, Hazlehurst L. Abstract 1547: Acquisition of resistance to the β1 integrin antagonist HYD1 correlates with decreased α4, α6, αV and β1 integrin expression and decreased adhesion to fibronectin, VCAM-1 and vitronectin Cancer Research. 70: 1547-1547. DOI: 10.1158/1538-7445.Am10-1547 |
0.399 |
|
| 2010 |
Sroka T, Pawar S, Pond G, Nagle R, Cress A. Blocking Integrin Function Combined with Ionizing Radiation for Eradication of Bone Metastasis International Journal of Radiation Oncology*Biology*Physics. 78: S622-S623. DOI: 10.1016/J.Ijrobp.2010.07.1448 |
0.747 |
|
| 2009 |
Sroka IC, Pond GD, Nagle RB, Porreca F, King T, Pestano G, Futscher BW, Gard JM, Riley J, Cress AE. Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. The Open Prostate Cancer Journal. 2: 59-66. PMID 22081777 DOI: 10.2174/1876822900902010059 |
0.413 |
|
| 2009 |
Nair RR, Emmons MF, Cress AE, Argilagos RF, Lam K, Kerr WT, Wang HG, Dalton WS, Hazlehurst LA. HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells. Molecular Cancer Therapeutics. 8: 2441-51. PMID 19671765 DOI: 10.1158/1535-7163.Mct-09-0113 |
0.382 |
|
| 2009 |
Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis. Cancer Research. 69: 5007-14. PMID 19491258 DOI: 10.1158/0008-5472.Can-09-0354 |
0.824 |
|
| 2008 |
Demetriou MC, Kwei KA, Powell MB, Nagle RB, Bowden GT, Cress AE. Integrin A6 Cleavage in Mouse Skin Tumors. The Open Cancer Journal. 2: 1-4. PMID 20664806 DOI: 10.2174/1874079000802010001 |
0.809 |
|
| 2008 |
King TE, Pawar SC, Majuta L, Sroka IC, Wynn D, Demetriou MC, Nagle RB, Porreca F, Cress AE. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. Plos One. 3: e3535. PMID 18958175 DOI: 10.1371/Journal.Pone.0003535 |
0.785 |
|
| 2008 |
Sroka IC, Chen ML, Cress AE. Simplified purification procedure of laminin-332 and laminin-511 from human cell lines. Biochemical and Biophysical Research Communications. 375: 410-3. PMID 18713621 DOI: 10.1016/J.Bbrc.2008.08.029 |
0.398 |
|
| 2008 |
Demetriou MC, Stylianou P, Andreou M, Yiannikouri O, Tsaprailis G, Cress AE, Skourides P. Spatially and temporally regulated alpha6 integrin cleavage during Xenopus laevis development. Biochemical and Biophysical Research Communications. 366: 779-85. PMID 18083114 DOI: 10.1016/J.Bbrc.2007.12.040 |
0.794 |
|
| 2007 |
Pawar SC, Dougherty S, Pennington ME, Demetriou MC, Stea BD, Dorr RT, Cress AE. alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation. International Journal of Radiation Biology. 83: 761-7. PMID 18058365 DOI: 10.1080/09553000701633135 |
0.8 |
|
| 2007 |
King T, Vardanyan A, Majuta L, Melemedjian O, Nagle R, Cress AE, Vanderah TW, Lai J, Porreca F. Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain. 132: 154-68. PMID 17706870 DOI: 10.1016/J.Pain.2007.06.026 |
0.331 |
|
| 2007 |
Pawar SC, Demetriou MC, Nagle RB, Bowden GT, Cress AE. Integrin alpha6 cleavage: a novel modification to modulate cell migration. Experimental Cell Research. 313: 1080-9. PMID 17303120 DOI: 10.1016/J.Yexcr.2007.01.006 |
0.799 |
|
| 2006 |
De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, et al. Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology & Therapy. 5: 1588-99. PMID 17224636 DOI: 10.4161/Cbt.5.12.3660 |
0.326 |
|
| 2006 |
Sroka TC, Marik J, Pennington ME, Lam KS, Cress AE. The minimum element of a synthetic peptide required to block prostate tumor cell migration. Cancer Biology & Therapy. 5: 1556-62. PMID 17102593 DOI: 10.4161/Cbt.5.11.3461 |
0.807 |
|
| 2006 |
Sroka TC, Pennington ME, Cress AE. Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. Carcinogenesis. 27: 1748-57. PMID 16537560 DOI: 10.1093/Carcin/Bgl005 |
0.793 |
|
| 2006 |
Kremer CL, Schmelz M, Cress AE. Integrin-dependent amplification of the G2 arrest induced by ionizing radiation. The Prostate. 66: 88-96. PMID 16114062 DOI: 10.1002/Pros.20316 |
0.487 |
|
| 2005 |
Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress AE. Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia (New York, N.Y.). 7: 799-808. PMID 16229802 DOI: 10.1593/Neo.05274 |
0.362 |
|
| 2005 |
Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodríguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Research : Bcr. 7: R669-80. PMID 16168112 DOI: 10.1186/Bcr1273 |
0.758 |
|
| 2005 |
Bair EL, Chen ML, McDaniel K, Sekiguchi K, Cress AE, Nagle RB, Bowden GT. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia (New York, N.Y.). 7: 380-9. PMID 15967115 DOI: 10.1593/Neo.04619 |
0.492 |
|
| 2005 |
Schmelz M, Moll R, Hesse U, Prasad AR, Gandolfi JA, Hasan SR, Bartholdi M, Cress AE. Identification of a stem cell candidate in the normal human prostate gland. European Journal of Cell Biology. 84: 341-54. PMID 15819412 DOI: 10.1016/J.Ejcb.2004.12.019 |
0.454 |
|
| 2004 |
Cress AE, Mohla S. Therapeutic targeting of prostate cancer. Cancer Biology & Therapy. 3: 1028-30. PMID 15539935 DOI: 10.4161/Cbt.3.10.1266 |
0.369 |
|
| 2004 |
Demetriou MC, Pennington ME, Nagle RB, Cress AE. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Experimental Cell Research. 294: 550-8. PMID 15023541 DOI: 10.1016/J.Yexcr.2003.11.023 |
0.828 |
|
| 2004 |
Demetriou MC, Cress AE. Integrin clipping: a novel adhesion switch? Journal of Cellular Biochemistry. 91: 26-35. PMID 14689578 DOI: 10.1002/Jcb.10675 |
0.832 |
|
| 2004 |
Chauhan S, Kunz S, Davis K, Roberts J, Martin G, Demetriou MC, Sroka TC, Cress AE, Miesfeld RL. Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling. The Journal of Biological Chemistry. 279: 937-44. PMID 14576147 DOI: 10.1074/Jbc.M311325200 |
0.776 |
|
| 2004 |
Schmelz M, Cress AE, Barrera J, McDaniel KM, Davis TL, Fuchs L, Dalkin BL, Nagle RB. Erratum: PEAZ-1: A new human prostate neoplastic epithelial cell line (Prostate (2001) 48 (79-92)) The Prostate. 61. DOI: 10.1002/Pros.20175 |
0.421 |
|
| 2003 |
Chauhan S, Pandey R, Way JF, Sroka TC, Demetriou MC, Kunz S, Cress AE, Mount DW, Miesfeld RL. Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation. Biochemical and Biophysical Research Communications. 310: 421-32. PMID 14521927 DOI: 10.1016/J.Bbrc.2003.08.147 |
0.761 |
|
| 2003 |
Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, Bowden GT. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Research. 63: 2292-9. PMID 12727852 |
0.364 |
|
| 2002 |
Parrish AR, Sallam K, Nyman DW, Orozco J, Cress AE, Dalkin BL, Nagle RB, Gandolfi AJ. Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biology and Toxicology. 18: 205-19. PMID 12083426 DOI: 10.1023/A:1015567805460 |
0.441 |
|
| 2002 |
Schmelz M, Cress AE, Scott KM, Bürger F, Cui H, Sallam K, McDaniel KM, Dalkin BL, Nagle RB. Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia (New York, N.Y.). 4: 243-54. PMID 11988844 DOI: 10.1038/Sj.Neo.7900223 |
0.493 |
|
| 2002 |
Whitacre DC, Chauhan S, Davis T, Gordon D, Cress AE, Miesfeld RL. Androgen induction of in vitro prostate cell differentiation. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 13: 1-11. PMID 11801526 |
0.334 |
|
| 2002 |
Schmelz M, Cress AE, Scott KM, Bürgery F, Cui H, Sallam K, McDaniel KM, Dalkin BL, Nagle RB. Different phenotypes in human prostate cancer Neoplasia. 4: 243-254. DOI: 10.1038/Sj/Neo/7900223 |
0.416 |
|
| 2001 |
Bair EL, Massey CP, Tran NL, Borchers AH, Heimark RL, Cress AE, Bowden GT. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Experimental Cell Research. 270: 259-67. PMID 11640889 DOI: 10.1006/Excr.2001.5347 |
0.474 |
|
| 2001 |
Schmelz M, Cress AE, Barrera J, McDaniel KM, Davis TL, Fuchs L, Dalkin BL, Nagle RB. PEAZ-1: a new human prostate neoplastic epithelial cell line. The Prostate. 48: 79-92. PMID 11433418 DOI: 10.1002/Pros.1084 |
0.43 |
|
| 2001 |
Davis TL, Rabinovitz I, Futscher BW, Schnölzer M, Burger F, Liu Y, Kulesz-Martin M, Cress AE. Identification of a novel structural variant of the alpha 6 integrin. The Journal of Biological Chemistry. 276: 26099-106. PMID 11359780 DOI: 10.1074/Jbc.M102811200 |
0.446 |
|
| 2001 |
DeRoock IB, Pennington ME, Sroka TC, Lam KS, Bowden GT, Bair EL, Cress AE. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. Cancer Research. 61: 3308-13. PMID 11309285 |
0.78 |
|
| 2001 |
Davis TL, Cress AE, Dalkin BL, Nagle RB. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. The Prostate. 46: 240-8. PMID 11170153 DOI: 10.1002/1097-0045(20010215)46:3<240::Aid-Pros1029>3.0.Co;2-0 |
0.455 |
|
| 2001 |
Cress AE. Quantitation of phosphotyrosine signals in human prostate cell adhesion sites. Biotechniques. 29: 776, 778, 780-1. PMID 11056807 DOI: 10.2144/00294St03 |
0.388 |
|
| 2000 |
Witkowski CM, Bowden GT, Nagle RB, Cress AE. Altered surface expression and increased turnover of the alpha6beta4 integrin in an undifferentiated carcinoma. Carcinogenesis. 21: 325-30. PMID 10657977 DOI: 10.1093/Carcin/21.2.325 |
0.423 |
|
| 1999 |
Tran NL, Nagle RB, Cress AE, Heimark RL. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. The American Journal of Pathology. 155: 787-98. PMID 10487836 DOI: 10.1016/S0002-9440(10)65177-2 |
0.433 |
|
| 1999 |
Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines Blood. 93: 1658-1667. DOI: 10.1182/Blood.V93.5.1658.405A19_1658_1667 |
0.31 |
|
| 1998 |
von Bredow DC, Cress AE, Howard EW, Bowden GT, Nagle RB. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. The Biochemical Journal. 965-72. PMID 9560329 DOI: 10.1042/Bj3310965 |
0.373 |
|
| 1997 |
von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of beta 4 integrin by matrilysin. Experimental Cell Research. 236: 341-5. PMID 9344615 DOI: 10.1006/Excr.1997.3711 |
0.352 |
|
| 1997 |
Mccandless JR, Cress AE, Rabinovitz I, Payne CM, Bowden GT, Knox JD, Nagle RB. A human xenograft model for testing early events of epithelial neoplastic invasion. International Journal of Oncology. 10: 279-285. DOI: 10.3892/Ijo.10.2.279 |
0.481 |
|
| 1996 |
Pennington ME, Lam KS, Cress AE. The use of a combinatorial library method to isolate human tumor cell adhesion peptides Molecular Diversity. 2: 19-28. PMID 9238629 DOI: 10.1007/Bf01718696 |
0.381 |
|
| 1996 |
Cress AE, Dalton WS. Multiple drug resistance and intermediate filaments. Cancer Metastasis Reviews. 15: 499-506. PMID 9034606 DOI: 10.1007/Bf00054015 |
0.414 |
|
| 1996 |
Cress AE, Rabinovitz I, Zhu W, Nagle RB. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Reviews. 14: 219-28. PMID 8548870 DOI: 10.1007/Bf00690293 |
0.471 |
|
| 1996 |
Woo C, Nagle RB, Stea B, Cress AE. 131 The integrin α6β4 as a signaling membrane protein for a damage response to ionizing radiation in human prostate cancer cell lines International Journal of Radiation Oncology*Biology*Physics. 36: 224. DOI: 10.1016/S0360-3016(97)85473-9 |
0.437 |
|
| 1995 |
von Bredow DC, Nagle RB, Bowden GT, Cress AE. Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products. Experimental Cell Research. 221: 83-91. PMID 7589259 DOI: 10.1006/Excr.1995.1355 |
0.408 |
|
| 1995 |
Rabinovitz I, Nagle RB, Cress AE. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clinical & Experimental Metastasis. 13: 481-91. PMID 7586806 DOI: 10.1007/Bf00118187 |
0.534 |
|
| 1994 |
Rabinovitz I, Cress AE, Nagle RB. Biosynthesis and secretion of laminin and S-laminin by human prostate carcinoma cell lines. The Prostate. 25: 97-107. PMID 8036181 DOI: 10.1002/Pros.2990250207 |
0.486 |
|
| 1994 |
Wallon UM, Shassetz LR, Cress AE, Bowden GT, Gerner EW. Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line. Molecular Carcinogenesis. 11: 138-44. PMID 7945802 DOI: 10.1002/Mc.2940110304 |
0.445 |
|
| 1994 |
Majda JA, Gerner EW, Vanlandingham B, Gehlsen KR, Cress AE. Heat shock-induced shedding of cell surface integrins in A549 human lung tumor cells in culture. Experimental Cell Research. 210: 46-51. PMID 7505747 DOI: 10.1006/Excr.1994.1007 |
0.429 |
|
| 1993 |
Peck VM, Gerner EW, Cress AE. A DNA polymerase alpha-associated 56 kDa protein kinase. Biochemical and Biophysical Research Communications. 190: 325-31. PMID 8427578 DOI: 10.1006/Bbrc.1993.1051 |
0.308 |
|
| 1993 |
Witkowski CM, Rabinovitz I, Nagle RB, Affinito KS, Cress AE. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. Journal of Cancer Research and Clinical Oncology. 119: 637-44. PMID 7688749 DOI: 10.1007/Bf01215981 |
0.509 |
|
| 1992 |
Short WO, Goodwill L, Taylor CW, Job C, Arthur ME, Cress AE. Alteration of human tumor cell adhesion by high-strength static magnetic fields. Investigative Radiology. 27: 836-40. PMID 1399440 DOI: 10.1097/00004424-199210000-00014 |
0.333 |
|
| 1992 |
Peck VM, Gerner EW, Cress AE. Delta-type DNA polymerase characterized from Drosophila melanogaster embryos. Nucleic Acids Research. 20: 5779-84. PMID 1360647 DOI: 10.1093/Nar/20.21.5779 |
0.307 |
|
| 1990 |
Seftor RE, Seftor EA, Cress AE, Hendrix MJ. Profiles of human melanoma cell surface proteins: effects of culturing on two different substrates. Pigment Cell Research. 3: 44-8. PMID 2143019 DOI: 10.1111/J.1600-0749.1990.Tb00261.X |
0.381 |
|
| 1990 |
Majda J, Cress A, Nagle R, Gehlsen K. Detection of human tumor epithelial micrometastases in bone marrow using antibodies to acidic keratins and integrin α3β1.(Project supported by a 1989–1990 ASTRO fellowship grant) International Journal of Radiation Oncology*Biology*Physics. 19: 211. DOI: 10.1016/0360-3016(90)90816-3 |
0.328 |
|
| 1989 |
Ostrowski LE, Krieg P, Finch J, Cress AE, Nagle RB, Bowden GT. Expression of beta-actin during progression of mouse skin tumors. Carcinogenesis. 10: 1439-44. PMID 2752518 DOI: 10.1093/Carcin/10.8.1439 |
0.364 |
|
| 1989 |
Roberts RA, Cress AE, Dalton WS. Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. Biochemical Pharmacology. 38: 4283-90. PMID 2597200 DOI: 10.1016/0006-2952(89)90527-3 |
0.32 |
|
| 1989 |
Bonham K, Embry T, Gibson D, Jaffe DR, Roberts RA, Cress AE, Bowden GT. Activation of the cellular Harvey ras gene in mouse skin tumors initiated with urethane. Molecular Carcinogenesis. 2: 34-9. PMID 2567173 DOI: 10.1002/Mc.2940020106 |
0.305 |
|
| 1987 |
Yamanishi DT, Bowden GT, Cress AE. An analysis of DNA replication in synchronized CHO cells treated with benzo[a]pyrene diol epoxide. Biochimica Et Biophysica Acta. 910: 34-42. PMID 3115292 DOI: 10.1016/0167-4781(87)90092-3 |
0.321 |
|
| 1980 |
Cress AE, Gerner EW. Ornithine decarboxylase induction in cells stimulated to proliferate differs from that in continuously dividing cells. The Biochemical Journal. 188: 375-80. PMID 6772164 DOI: 10.1042/Bj1880375 |
0.363 |
|
| 1978 |
Cress AE, Gerner EW. Hydroxyurea treatment affects the G1 phase in next generation CHO cells. Experimental Cell Research. 110: 347-53. PMID 590360 DOI: 10.1016/0014-4827(77)90301-9 |
0.327 |
|
| Show low-probability matches. |